102 related articles for article (PubMed ID: 28876137)
1. Penetrance and the Healthy Elderly.
Lacaze P; Winship I; McNeil J
Genet Test Mol Biomarkers; 2017 Nov; 21(11):637-640. PubMed ID: 28876137
[TBL] [Abstract][Full Text] [Related]
2. Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals.
Lacaze P; Sebra R; Riaz M; Tiller J; Revote J; Phung J; Parker EJ; Orchard SG; Lockery JE; Wolfe R; Strahl M; Wang YC; Chen R; Sisco D; Arnold T; Thompson BA; Buchanan DD; Macrae FA; James PA; Abhayaratna WP; Lockett TJ; Gibbs P; Tonkin AM; Nelson MR; Reid CM; Woods RL; Murray AM; Winship I; McNeil JJ; Schadt E
Genet Med; 2020 Nov; 22(11):1883-1886. PubMed ID: 32606442
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic variants in the healthy elderly: unique ethical and practical challenges.
Lacaze P; Ryan J; Woods R; Winship I; McNeil J
J Med Ethics; 2017 Oct; 43(10):714-722. PubMed ID: 28341755
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Penetrance of Deleterious Clinical Variants.
Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R
JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.
Bernstein-Molho R; Friedman E; Kedar I; Laitman Y; Allweis TM; Gal-Yam EN; Feldman HB; Grinshpun A; Halpern N; Hartmajer S; Kadouri L; Katz LH; Kaufman B; Laish I; Levanon K; Philipsborn SL; Ludman M; Moran G; Peretz T; Reinstein E; Levi GR; Safra T; Shkedi S; Vinkler C; Levy Z; Goldberg Y
Breast Cancer Res Treat; 2020 Jun; 181(2):445-453. PubMed ID: 32303989
[TBL] [Abstract][Full Text] [Related]
6. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.
Natarajan P; Gold NB; Bick AG; McLaughlin H; Kraft P; Rehm HL; Peloso GM; Wilson JG; Correa A; Seidman JG; Seidman CE; Kathiresan S; Green RC
Sci Transl Med; 2016 Nov; 8(364):364ra151. PubMed ID: 27831900
[TBL] [Abstract][Full Text] [Related]
7. The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly.
Pinese M; Lacaze P; Rath EM; Stone A; Brion MJ; Ameur A; Nagpal S; Puttick C; Husson S; Degrave D; Cristina TN; Kahl VFS; Statham AL; Woods RL; McNeil JJ; Riaz M; Barr M; Nelson MR; Reid CM; Murray AM; Shah RC; Wolfe R; Atkins JR; Fitzsimmons C; Cairns HM; Green MJ; Carr VJ; Cowley MJ; Pickett HA; James PA; Powell JE; Kaplan W; Gibson G; Gyllensten U; Cairns MJ; McNamara M; Dinger ME; Thomas DM
Nat Commun; 2020 Jan; 11(1):435. PubMed ID: 31974348
[TBL] [Abstract][Full Text] [Related]
8. Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes.
Taeubner J; Wieczorek D; Yasin L; Brozou T; Borkhardt A; Kuhlen M
Trends Cancer; 2018 Nov; 4(11):718-728. PubMed ID: 30352675
[TBL] [Abstract][Full Text] [Related]
9. The ASPREE Healthy Ageing Biobank: Methodology and participant characteristics.
Parker EJ; Orchard SG; Gilbert TJ; Phung JJ; Owen AJ; Lockett T; Nelson MR; Reid CM; Tonkin AM; Abhayaratna WP; Gibbs P; McNeil JJ; Woods RL
PLoS One; 2024; 19(2):e0294743. PubMed ID: 38421995
[TBL] [Abstract][Full Text] [Related]
10. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
Kingdom R; Wright CF
Front Genet; 2022; 13():920390. PubMed ID: 35983412
[TBL] [Abstract][Full Text] [Related]
11. The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design.
Lacaze P; Pinese M; Kaplan W; Stone A; Brion MJ; Woods RL; McNamara M; McNeil JJ; Dinger ME; Thomas DM
Eur J Hum Genet; 2019 Feb; 27(2):308-316. PubMed ID: 30353151
[TBL] [Abstract][Full Text] [Related]
12. The genomic potential of the Aspirin in Reducing Events in the Elderly and Statins in Reducing Events in the Elderly studies.
Lacaze P; Woods R; Zoungas S; McNeil J; ; ;
Intern Med J; 2017 Apr; 47(4):461-463. PubMed ID: 28401726
[TBL] [Abstract][Full Text] [Related]
13. Quantifying prion disease penetrance using large population control cohorts.
Minikel EV; Vallabh SM; Lek M; Estrada K; Samocha KE; Sathirapongsasuti JF; McLean CY; Tung JY; Yu LP; Gambetti P; Blevins J; Zhang S; Cohen Y; Chen W; Yamada M; Hamaguchi T; Sanjo N; Mizusawa H; Nakamura Y; Kitamoto T; Collins SJ; Boyd A; Will RG; Knight R; Ponto C; Zerr I; Kraus TF; Eigenbrod S; Giese A; Calero M; de Pedro-Cuesta J; Haïk S; Laplanche JL; Bouaziz-Amar E; Brandel JP; Capellari S; Parchi P; Poleggi A; Ladogana A; O'Donnell-Luria AH; Karczewski KJ; Marshall JL; Boehnke M; Laakso M; Mohlke KL; Kähler A; Chambert K; McCarroll S; Sullivan PF; Hultman CM; Purcell SM; Sklar P; van der Lee SJ; Rozemuller A; Jansen C; Hofman A; Kraaij R; van Rooij JG; Ikram MA; Uitterlinden AG; van Duijn CM; ; Daly MJ; MacArthur DG
Sci Transl Med; 2016 Jan; 8(322):322ra9. PubMed ID: 26791950
[TBL] [Abstract][Full Text] [Related]
14. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
[TBL] [Abstract][Full Text] [Related]
15. Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.
Downs B; Sherman S; Cui J; Kim YC; Snyder C; Christensen M; Luo J; Lynch H; Wang SM
Eur J Cancer; 2019 Jan; 107():68-78. PubMed ID: 30551077
[TBL] [Abstract][Full Text] [Related]
16. Genomic Sequencing Expansion and Incomplete Penetrance.
Shieh JTC
Pediatrics; 2019 Jan; 143(Suppl 1):S22-S26. PubMed ID: 30600267
[TBL] [Abstract][Full Text] [Related]
17. Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing.
Lorca V; Rueda D; Martín-Morales L; Fernández-Aceñero MJ; Grolleman J; Poves C; Llovet P; Tapial S; García-Barberán V; Sanz J; Pérez-Segura P; de Voer RM; Díaz-Rubio E; de la Hoya M; Caldés T; Garre P
Sci Rep; 2019 Jul; 9(1):9814. PubMed ID: 31285513
[TBL] [Abstract][Full Text] [Related]
18. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.
Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L
Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624
[TBL] [Abstract][Full Text] [Related]
19. Estimating the penetrance of pathogenic gene variants in families with missing pedigree information.
Jonker MA; Rijken JA; Hes FJ; Putter H; Hensen EF
Stat Methods Med Res; 2019; 28(10-11):2924-2936. PubMed ID: 30073909
[TBL] [Abstract][Full Text] [Related]
20. Genetic predispositions to acute and chronic pancreatitis.
Whitcomb DC
Med Clin North Am; 2000 May; 84(3):531-47, vii. PubMed ID: 10872412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
